SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Recent filings
Filed 2026-04-01 17:11
Tx date 2026-04-01 		$FRX
Fennec Pharmaceuticals Inc. 		Raykov, Rostislav Christov
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-69,069.26
-10,946 vol
$6.31 each 		2,729,881
Filed 2026-04-01 17:08
Tx date 2026-04-01 		$FRX
Fennec Pharmaceuticals Inc. 		Raykov, Rostislav Christov
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$38,215
+15,598 vol
$2.45 each 		2,740,827
Filed 2026-04-01 17:07
Tx date 2026-04-01 		$FRX
Fennec Pharmaceuticals Inc. 		Raykov, Rostislav Christov
4 - Director of Issuer
Direct Ownership
Options
10 - Acquisition or disposition in the public market 		$-38,215.10
-15,598 vol
$2.45 each 		21,451,651
Filed 2026-04-01 12:54
Tx date 2026-03-31 		$FRX
Fennec Pharmaceuticals Inc. 		Raykov, Rostislav Christov
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
+5,208 vol 		2,725,229
Filed 2026-04-01 12:52
Tx date 2026-03-31 		$FRX
Fennec Pharmaceuticals Inc. 		Sayad, Pierre
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
+20,679 vol 		20,679
Filed 2026-04-01 12:52
Tx date 2024-10-28 		$FRX
Fennec Pharmaceuticals Inc. 		Sayad, Pierre
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2026-04-01 12:50
Tx date 2026-03-31 		$FRX
Fennec Pharmaceuticals Inc. 		Hackman, Jeffrey
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
+31,797 vol 		60,507
Filed 2026-04-01 12:48
Tx date 2026-03-31 		$FRX
Fennec Pharmaceuticals Inc. 		Evans, Terry
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
+20,679 vol 		20,679
Filed 2026-04-01 12:48
Tx date 2024-10-28 		$FRX
Fennec Pharmaceuticals Inc. 		Evans, Terry
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2026-04-01 12:46
Tx date 2026-03-31 		$FRX
Fennec Pharmaceuticals Inc. 		Cioffi, Christiana
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
+19,165 vol 		19,165
Filed 2026-04-01 12:46
Tx date 2024-10-28 		$FRX
Fennec Pharmaceuticals Inc. 		Cioffi, Christiana
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2026-04-01 12:43
Tx date 2026-03-31 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
+29,207 vol 		317,707
Older filings
Filed 2026-03-03 11:33
Tx date 2026-03-02 		$FRX
Fennec Pharmaceuticals Inc. 		Raykov, Rostislav Christov
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-84,361.23
-10,079 vol
$8.37 each 		2,720,021
Filed 2026-03-03 11:31
Tx date 2026-03-02 		$FRX
Fennec Pharmaceuticals Inc. 		Raykov, Rostislav Christov
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$38,215
+15,598 vol
$2.45 each 		2,730,100
Filed 2026-03-03 11:30
Tx date 2026-03-02 		$FRX
Fennec Pharmaceuticals Inc. 		Raykov, Rostislav Christov
4 - Director of Issuer
Direct Ownership
Options
10 - Acquisition or disposition in the public market 		$38,215
+15,598 vol
$2.45 each 		21,467,249
Filed 2026-03-03 11:24
Tx date 2026-03-02 		$FRX
Fennec Pharmaceuticals Inc. 		Raykov, Rostislav Christov
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
+5,208 vol 		2,714,502
Filed 2026-03-03 11:23
Tx date 2026-03-02 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
+1,191 vol 		288,500
Filed 2026-02-24 15:48
Tx date 2026-02-19 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
+27,285 vol 		287,309
Filed 2026-02-24 15:47
Tx date 2026-02-19 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$9,996
+2,450 vol
$4.08 each 		260,024
Filed 2026-02-24 15:46
Tx date 2026-02-19 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Options
10 - Acquisition or disposition in the public market 		$-9,996
-2,450 vol
$4.08 each 		779,330